Back

Incidence of intracranial hemorrhage in the years 2013-15 in patients with atrial fibrillation in anticoagulant therapy: preliminary analysis of data from Ravenna registers

28 August 2016 (14:00 - 18:00)
Organised by:
Add to my library
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation III Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Cinzia Gatti

Ospedale S. Maria alle Croci, Ravenna (Italy)

24 More presentations in this session

Presentation thumbnail
Professor D. Xavier (Bangalore, IN)
Abstract Slides
Presentation thumbnail
Doctor D. Iglesias (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor J. Wieczorek (Katowice, PL)
Abstract Slides
Presentation thumbnail
Associate Professor A. Parwani (Berlin, DE)
Presentation thumbnail
Doctor P. Chan (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation III

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of left atrial appendage closure on events after intracranial haemorrhage in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry
1 September 2025
thumbnail
Congress Presentation
Preliminary results of studying the prevalence of atrial fibrillation and the adequacy of prevention of thromboembolic complications
26 August 2023
thumbnail
Congress Presentation
Blood pressure levels and risk of haemorrhagic stroke in patients with atrial fibrillation and anticoagulants: results from a primary care cohort with hypertension
1 September 2020
thumbnail
Congress Presentation
Use of direct oral anticoagulants in patients with atrial fibrillation and cancer: a subanalysis of the nationwide Italian START registry.
20 June 2025

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources